DE60017878D1 - Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sind - Google Patents
Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sindInfo
- Publication number
- DE60017878D1 DE60017878D1 DE60017878T DE60017878T DE60017878D1 DE 60017878 D1 DE60017878 D1 DE 60017878D1 DE 60017878 T DE60017878 T DE 60017878T DE 60017878 T DE60017878 T DE 60017878T DE 60017878 D1 DE60017878 D1 DE 60017878D1
- Authority
- DE
- Germany
- Prior art keywords
- angiogenesis
- treatment
- diseases associated
- combination preparations
- formation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Immunology (AREA)
- Rheumatology (AREA)
- Ophthalmology & Optometry (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Endocrinology (AREA)
- Pain & Pain Management (AREA)
- Hematology (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
- Electrotherapy Devices (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9903404.3A GB9903404D0 (en) | 1999-02-16 | 1999-02-16 | Methods of treatment and compositions useful for the treatment of diseases involving angiogenesis |
GB9903404 | 1999-02-16 | ||
PCT/GB2000/000511 WO2000048591A1 (en) | 1999-02-16 | 2000-02-15 | Combinations for the treatment of diseases involving angiogenesis |
Publications (2)
Publication Number | Publication Date |
---|---|
DE60017878D1 true DE60017878D1 (de) | 2005-03-10 |
DE60017878T2 DE60017878T2 (de) | 2006-01-26 |
Family
ID=10847791
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE60017878T Expired - Fee Related DE60017878T2 (de) | 1999-02-16 | 2000-02-15 | Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sind |
Country Status (21)
Country | Link |
---|---|
US (2) | US7087627B1 (de) |
EP (1) | EP1161235B1 (de) |
JP (1) | JP4708569B2 (de) |
KR (2) | KR20070034642A (de) |
CN (1) | CN1344159B (de) |
AT (1) | ATE288264T1 (de) |
AU (1) | AU775242B2 (de) |
BR (1) | BR0008254A (de) |
CA (1) | CA2362281C (de) |
DE (1) | DE60017878T2 (de) |
DK (1) | DK1161235T3 (de) |
ES (1) | ES2237407T3 (de) |
GB (1) | GB9903404D0 (de) |
HK (1) | HK1040919B (de) |
IL (2) | IL144847A0 (de) |
MX (1) | MXPA01008245A (de) |
NO (1) | NO20013966L (de) |
NZ (1) | NZ513429A (de) |
PT (1) | PT1161235E (de) |
WO (1) | WO2000048591A1 (de) |
ZA (1) | ZA200106688B (de) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2001247459A (ja) | 2000-03-03 | 2001-09-11 | Oakland Uniservices Ltd | 癌の組み合わせ療法 |
EE200200565A (et) | 2000-03-31 | 2004-06-15 | Angiogene Pharmaceuticals Ltd. | Vaskulaarse kahjustava toimega kombinatsioonravi |
AU2001282717A1 (en) | 2000-07-28 | 2002-02-13 | Cancer Research Technology Limited | Cancer treatment by combination therapy |
US20050153939A1 (en) | 2003-09-10 | 2005-07-14 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono-and di-organic amine salts, mono-and di-amino acid salts, and mono-and di-amino acid ester salts |
US6670344B2 (en) | 2000-09-14 | 2003-12-30 | Bristol-Myers Squibb Company | Combretastatin A-4 phosphate prodrug mono- and di-organic amine salts, mono- and di- amino acid salts, and mono- and di-amino acid ester salts |
YU29803A (sh) * | 2000-10-27 | 2006-05-25 | Aventis Pharma S.A. | Kombinacija kamptotekina i derivata stilbena za lečenje raka |
AU2002246827B2 (en) * | 2000-12-22 | 2008-02-21 | Bristol-Myers Squibb Company | Methods for modulating tumor growth and metastasis |
US20020183266A1 (en) * | 2001-03-15 | 2002-12-05 | Aventis Pharma, S.A. | Combination comprising combretastatin and anticancer agents |
AU2008202468B2 (en) * | 2001-07-13 | 2011-08-11 | Oxigene, Inc. | Compositions and Methods of Administering Tubulin Binding Agents for the Treatment of Ocular Diseases |
CN1527704B (zh) * | 2001-07-13 | 2011-05-18 | 奥克斯吉尼有限公司 | 治疗眼病的组合物和微管蛋白结合剂用法 |
ES2252160T3 (es) * | 2001-08-30 | 2006-05-16 | Cancer Research Technology Limited | Combinaciones anticancerosas de dmxaa y paclitaxel o docetaxel. |
GB0121285D0 (en) * | 2001-09-03 | 2001-10-24 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2386836B (en) | 2002-03-22 | 2006-07-26 | Cancer Res Ventures Ltd | Anti-cancer combinations |
GB2394658A (en) | 2002-11-01 | 2004-05-05 | Cancer Rec Tech Ltd | Oral anti-cancer composition |
CA2669138A1 (en) * | 2006-11-09 | 2008-12-04 | University Of Maryland, Baltimore | Use of 5,6-dimethylxanthenone-4-acetic acid as an antimicrobial agent |
WO2008100591A2 (en) * | 2007-02-14 | 2008-08-21 | The General Hospital Corporation | Modulation of nitric oxide signaling to normalize tumor vasculature |
PL2219451T3 (pl) | 2007-11-21 | 2015-04-30 | Oxigene Inc | Sposób leczenia nowotworów tkanek krwiotwórczych |
US9353150B2 (en) | 2012-12-04 | 2016-05-31 | Massachusetts Institute Of Technology | Substituted pyrazino[1′,2′:1 ,5]pyrrolo[2,3-b]-indole-1,4-diones for cancer treatment |
AU2014228822A1 (en) | 2013-03-15 | 2015-10-01 | Memorial Sloan-Kettering Cancer Center | HSP90-targeted cardiac imaging and therapy |
WO2017031157A1 (en) | 2015-08-18 | 2017-02-23 | Mateon Therapeutics, Inc. | Use of vdas to enhance immunomodulating therapies against tumors |
WO2017197045A1 (en) | 2016-05-11 | 2017-11-16 | Movassaghi Mohammad | Convergent and enantioselective total synthesis of communesin analogs |
US10640508B2 (en) | 2017-10-13 | 2020-05-05 | Massachusetts Institute Of Technology | Diazene directed modular synthesis of compounds with quaternary carbon centers |
WO2020247054A1 (en) | 2019-06-05 | 2020-12-10 | Massachusetts Institute Of Technology | Compounds, conjugates, and compositions of epipolythiodiketopiperazines and polythiodiketopiperazines and uses thereof |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL107771A0 (en) | 1992-11-27 | 1994-02-27 | Wellcome Found | Pharmaceutical compositions containing isothiourea derivatives certain such novel compounds and their preparation |
US5554638A (en) * | 1993-05-24 | 1996-09-10 | Duke University | Methods for improving therapeutic effectiveness of agents for the treatment of solid tumors and other disorders |
US5424447A (en) | 1993-07-07 | 1995-06-13 | The Medical College Of Wisconsin Research Foundation, Inc. | Heme binding compounds and use thereof |
GB9320484D0 (en) * | 1993-10-05 | 1993-11-24 | Wellcome Found | Pharmaceutical combinations |
WO1996018617A1 (en) * | 1994-12-12 | 1996-06-20 | Merck & Co., Inc. | Substituted 2-acylamino-pyridines as inhibitors of nitric oxide synthase |
AU2213197A (en) * | 1996-03-05 | 1997-09-22 | Medinox, Inc. | Combinational therapeutic methods employing nitric oxide scavengers and compositions useful therefor |
MY117948A (en) | 1997-01-13 | 2004-08-30 | Glaxo Group Ltd | Nitride oxide synthase inhibitors. |
US5916910A (en) * | 1997-06-04 | 1999-06-29 | Medinox, Inc. | Conjugates of dithiocarbamates with pharmacologically active agents and uses therefore |
-
1999
- 1999-02-16 GB GBGB9903404.3A patent/GB9903404D0/en not_active Ceased
-
2000
- 2000-02-15 EP EP00903832A patent/EP1161235B1/de not_active Expired - Lifetime
- 2000-02-15 CN CN008050961A patent/CN1344159B/zh not_active Expired - Fee Related
- 2000-02-15 AU AU25590/00A patent/AU775242B2/en not_active Ceased
- 2000-02-15 CA CA002362281A patent/CA2362281C/en not_active Expired - Fee Related
- 2000-02-15 AT AT00903832T patent/ATE288264T1/de not_active IP Right Cessation
- 2000-02-15 DE DE60017878T patent/DE60017878T2/de not_active Expired - Fee Related
- 2000-02-15 US US09/890,989 patent/US7087627B1/en not_active Expired - Fee Related
- 2000-02-15 JP JP2000599383A patent/JP4708569B2/ja not_active Expired - Fee Related
- 2000-02-15 KR KR1020077004923A patent/KR20070034642A/ko not_active Application Discontinuation
- 2000-02-15 ES ES00903832T patent/ES2237407T3/es not_active Expired - Lifetime
- 2000-02-15 MX MXPA01008245A patent/MXPA01008245A/es active IP Right Grant
- 2000-02-15 KR KR1020017010121A patent/KR20010102038A/ko active IP Right Grant
- 2000-02-15 WO PCT/GB2000/000511 patent/WO2000048591A1/en not_active Application Discontinuation
- 2000-02-15 BR BR0008254-6A patent/BR0008254A/pt not_active Application Discontinuation
- 2000-02-15 NZ NZ513429A patent/NZ513429A/en not_active IP Right Cessation
- 2000-02-15 PT PT00903832T patent/PT1161235E/pt unknown
- 2000-02-15 DK DK00903832T patent/DK1161235T3/da active
- 2000-02-15 IL IL14484700A patent/IL144847A0/xx active IP Right Grant
-
2001
- 2001-08-09 IL IL144847A patent/IL144847A/en not_active IP Right Cessation
- 2001-08-14 ZA ZA200106688A patent/ZA200106688B/en unknown
- 2001-08-15 NO NO20013966A patent/NO20013966L/no unknown
-
2002
- 2002-04-08 HK HK02102577.5A patent/HK1040919B/zh not_active IP Right Cessation
-
2006
- 2006-05-01 US US11/416,283 patent/US20060198846A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
JP2002537251A (ja) | 2002-11-05 |
NZ513429A (en) | 2003-10-31 |
CA2362281A1 (en) | 2000-08-24 |
ATE288264T1 (de) | 2005-02-15 |
IL144847A (en) | 2006-10-31 |
US7087627B1 (en) | 2006-08-08 |
EP1161235B1 (de) | 2005-02-02 |
DK1161235T3 (da) | 2005-05-09 |
WO2000048591A1 (en) | 2000-08-24 |
JP4708569B2 (ja) | 2011-06-22 |
MXPA01008245A (es) | 2002-10-23 |
EP1161235A1 (de) | 2001-12-12 |
DE60017878T2 (de) | 2006-01-26 |
ES2237407T3 (es) | 2005-08-01 |
CN1344159A (zh) | 2002-04-10 |
KR20010102038A (ko) | 2001-11-15 |
HK1040919B (zh) | 2005-05-13 |
KR20070034642A (ko) | 2007-03-28 |
AU775242B2 (en) | 2004-07-22 |
IL144847A0 (en) | 2002-06-30 |
HK1040919A1 (en) | 2002-06-28 |
NO20013966D0 (no) | 2001-08-15 |
AU2559000A (en) | 2000-09-04 |
CA2362281C (en) | 2008-11-18 |
NO20013966L (no) | 2001-10-15 |
GB9903404D0 (en) | 1999-04-07 |
PT1161235E (pt) | 2005-05-31 |
ZA200106688B (en) | 2002-08-14 |
US20060198846A1 (en) | 2006-09-07 |
CN1344159B (zh) | 2011-09-28 |
BR0008254A (pt) | 2001-11-06 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE60017878D1 (de) | Kombinationspräparate zur behandlung von erkrankungen, die mit angiogenese verbunden sind | |
KR960703603A (ko) | 프로게스테론형 제제 및 산화질소 합성효소 기질 및 산화질소 공여물질의 배합물을 사용한 자간전증 및 조산의 치료(Combination of a Progestational Agent and a Nitric Oxide Synthase substrate and/or Donor for the Treatment of Preeclampsia and Preterm Labor) | |
NO308794B1 (no) | Farmakologisk aktive pyridin-derivater, preparater inneholdende forbindelsene samt forbindelsenes anvendelse | |
BR0007527A (pt) | Fenilfenantridinas com atividade inibitória depde-iv | |
NZ513629A (en) | C-21 modified epothilones | |
BR9306371A (pt) | Composições refrescantes | |
BR0112160A (pt) | Agentes antiinflamatórios seletivos para glicocorticóides | |
PT915898E (pt) | Forma i cristalina de claritromicina | |
DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
TR199802676A2 (xx) | T�m�rlerin, t�m�rle ilgili hastal�klar�n ve ka�eksinin tedavisi ve �nlenmesi i�in y�ntem. | |
ATE275393T1 (de) | Feste dispersionen mit nitrataktiven wirkstoffen | |
AU2291097A (en) | Novel phenanthridines substituted in the 6 position | |
CO5001019A1 (es) | Composicion emulsionable para la represion de insectos, que se deriva del tipo de fenilpirazoles sustituidos en posi- cion 1, y no favorecen la formacion de cristales | |
DK1313462T3 (da) | Anvendelse af asiatisk syre eller asiaticosid til behandling af cancer | |
WO2002070469A3 (en) | Selective pde3b inhibitors and use of the same in therapy | |
SE9604348D0 (sv) | Användning av hydroxyguanidiner | |
RS50148B (sr) | Upotreba docetaksela za lečenje hepatoćelijskog karcinoma | |
ES2088128T3 (es) | Aminosulfonilureas inhibidoras de acat. | |
MXPA03001455A (es) | Compuestos de pirazol, composiciones farmaceuticas y metodos para modular o inhibir la actividad del amiloide-beta-peptido asociado a reticulo endoplasmico y l-3-hidroxiacil-coa-deshidrogenasa. | |
BR0116205A (pt) | 2-piridonas antimicrobianas, suas composições e usos | |
DE50111407D1 (de) | Mittel enthaltend n-chlortaurin sowie dessen verwendung zur behandlung von schleimhautpolypen | |
FR2694694B1 (fr) | Composition active pour le traitement du psoriasis, notamment le psoriasis du cuir chevelu. | |
ATE323493T1 (de) | Gesteuerte freisetzung von antidepressiva | |
HK1050203A1 (en) | Novel fusidic acid derivatives. | |
ES2185154T3 (es) | Metodo de uso de inhibidores de la ciclooxigenasa-2 en el tratamiento y prevencion de la demencia. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
8327 | Change in the person/name/address of the patent owner |
Owner name: THE MAGDALEN CENTRE THE OXFORD SCIENCE PARK, WATLI |
|
8327 | Change in the person/name/address of the patent owner |
Owner name: ANGIOGENE PHARMACEUTICALS LTD., WATLINGTON, OXFORD |
|
8364 | No opposition during term of opposition | ||
8339 | Ceased/non-payment of the annual fee |